iShares Health Innovation Active ETF
Limited financial coverage for BMED.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
About the company
BMED focuses on total return by investing in the broad health sciences group of industries from R&D to production and distribution of medical supplies in different fields, including dental, optical or pharmaceuticals. It also involves healthcare providers including health facilities and hospitals or those providing related administrative, management or financial support. The fund reaches into non-human health (e.
- CEO
- Mark Velleca
- IPO
- 2020
- Employees
- 79
- HQ
- San Francisco, MA, US
Price Chart
- Market Cap
- $4.75M
- Div Yield
- 0.26%
- 52W High
- $32.19
- 52W Low
- $24.50
- 50D MA
- $28.42
- 200D MA
- $29.17
- Beta
- 0.80
- Avg Volume
- 2.34K
Get TickerSpark's AI analysis on BMED
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our BMED coverage
Recent articles, reports, and earnings notes.
No research on BMED yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BMED report →Similar companies
Peers in the same neighborhood.